108 related articles for article (PubMed ID: 38841623)
1. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach.
Jia W; Li N; Wang J; Gong X; Ouedraogo SY; Wang Y; Zhao J; Grech G; Chen L; Zhan X
EPMA J; 2024 Jun; 15(2):375-404. PubMed ID: 38841623
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
[TBL] [Abstract][Full Text] [Related]
4. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
[TBL] [Abstract][Full Text] [Related]
5. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
[TBL] [Abstract][Full Text] [Related]
6. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes.
Jia W; Gong X; Ye Z; Li N; Zhan X
EPMA J; 2023 Dec; 14(4):673-696. PubMed ID: 38094577
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicineĀ and based on a 101-combination machine learning computational framework.
Liu J; Shi Y; Zhang Y
EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
10. A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data.
Zhou Z; Jin H; Xu J
Ann Transl Med; 2023 Jan; 11(1):20. PubMed ID: 36760264
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
Zhang ZC; Guo JN; Zhang N; Wang ZQ; Lou G; Cui BB; Yang C
Front Immunol; 2021; 12():763791. PubMed ID: 34880862
[TBL] [Abstract][Full Text] [Related]
12. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.
Li N; Zhan X
EPMA J; 2020 Jun; 11(2):289-309. PubMed ID: 32549918
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
14. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.
Li N; Zhan X
EPMA J; 2019 Sep; 10(3):273-290. PubMed ID: 31462944
[TBL] [Abstract][Full Text] [Related]
15. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer.
Li N; Li B; Zhan X
Front Genet; 2021; 12():616073. PubMed ID: 33679883
[TBL] [Abstract][Full Text] [Related]
17. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
[TBL] [Abstract][Full Text] [Related]
18. Identification of Immune-Related Genes for Risk Stratification in Multiple Myeloma Based on Whole Bone Marrow Gene Expression Profiling.
Wang QS; Shi QQ; Meng Y; Chen MP; Hou J
Front Genet; 2022; 13():897886. PubMed ID: 35692836
[No Abstract] [Full Text] [Related]
19. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma.
Cao X; Ji Y; Li J; Liu Z; Chen C
Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]